Dennis E. Niewoehner, MD, is on the speakers’ bureaus for Boehringer-Ingelheim and Sepracor, Inc., and serves as a consultant for GlaxoSmithKline and AstraZeneca.
Susan Collazo, RN, MSN, NP-C, has nothing to disclose with regard to commercial support.
William C. Kohlhepp, DHSc, PA-C, has no financial relationship with the grantor and/or any commercial interest. Mr. Kohlhepp owns stock in Pfizer Inc.
Claire Murphy, RN, MSN, NP-C, has nothing to disclose with regard to commercial support.
Gabriel R. Ortiz, MPAS, PA-C, DFAAPA, serves as a consultant and is on the speakers’ bureaus for AstraZeneca, Boehringer-Ingelheim, Genentech Inc., Schering-Plough Corporation, sanofi-aventis, TEVA/TEVA Specialty Pharmaceuticals; Sepracor, Inc., Phadia US Inc./Quest Diagnostics, Pfizer Inc., and UCB.
This program is supported by an educational grant from Boehringer-Ingelheim and Pfizer Inc.